RhythmAnalytics vs Ligence Heart

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Ligence

AI Verdict

RhythmAnalytics by Biofourmis is designed for AI-powered interpretation of cardiac arrhythmias from single-lead ECG data, aiding in the diagnosis of rhythm disorders. Ligence Heart, on the other hand, automates the analysis and reporting of 2D transthoracic echocardiography, focusing on structural and functional heart assessments. While both are FDA-cleared cardiology AI tools, they address distinct diagnostic modalities and specific clinical challenges within cardiology.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare professionals seeking enhanced clinical decision support for detecting and classifying over 15 types of arrhythmias from compatible ECG devices, including Holter monitors and wearable sensors. It excels in scenarios requiring detailed rhythm analysis and beat-by-beat morphology computation.

View RhythmAnalytics →

Choose Ligence Heart if…

Choose Ligence Heart if your focus is on automating and standardizing the analysis and reporting of 2D transthoracic echocardiography studies. This platform is best suited for cardiologists and sonographers aiming to improve diagnostic efficiency and accuracy by leveraging AI for automated view classification, measurement calculations, and disease recognition for conditions like heart failure and valvular diseases. It seamlessly integrates with existing PACS, EHR, and RIS systems to streamline workflows.

View Ligence Heart →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Ligence Heart
Pricing Contact vendor Contact-for-pricing
Deployment Cloud-based API Cloud-based; on-premise; hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart (Tool B) is a web-based platform with an intuitive interface designed to resemble existing programs, offering automated reporting and streamlined workflows for clinicians. RhythmAnalytics (Tool A), primarily an API, relies on integration into other systems, making its direct end-user experience dependent on the implementing solution. Ligence Heart's focus on a direct, user-friendly clinical interface gives it an advantage in usability.

Clinical Value

Ligence Heart

Both tools are FDA-cleared and clinically validated in their respective domains. RhythmAnalytics (Tool A) provides highly accurate, automated interpretation of cardiac arrhythmias from ECG data. Ligence Heart (Tool B) offers comprehensive automated analysis of 2D transthoracic echocardiography, including view classification, advanced measurements, and disease recognition for multiple conditions, with studies suggesting its AI can match or even surpass human experts in some measurements.

Pricing & Value

Tie

Neither RhythmAnalytics (Tool A) nor Ligence Heart (Tool B) provides transparent pricing information, both requiring direct contact with the vendor for quotes. This lack of public pricing details makes it impossible to conduct a head-to-head comparison of their value propositions. Therefore, a definitive winner cannot be determined in this dimension.

Enterprise Readiness

Ligence Heart

Ligence Heart (Tool B) demonstrates stronger enterprise readiness by offering flexible deployment options (cloud, on-premise, hybrid) and explicitly stating it has a Business Associate Agreement (BAA). It also highlights integration capabilities with existing hospital systems like PACS, EHR, and RIS. RhythmAnalytics (Tool A) is cloud-based API with HIPAA compliance but does not specify BAA availability or as broad deployment flexibility.

Innovation

Ligence Heart

Both tools leverage AI for significant innovation in cardiology. RhythmAnalytics (Tool A) provides advanced AI for detailed ECG arrhythmia detection. However, Ligence Heart (Tool B) showcases a slightly higher degree of innovation by automating the comprehensive and complex analysis of echocardiography, including view classification, advanced measurements like strain and Doppler, and disease recognition, with research indicating its AI can sometimes outperform human measurements.

Support & Docs

Ligence Heart

Ligence Heart (Tool B) provides more explicit information regarding customer support channels, including a dedicated support email and an Information Security Officer contact. It also mentions the availability of user manuals, instructions for use (IFU), and training videos for operators. RhythmAnalytics (Tool A) does not provide specific details on support or documentation in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Ligence Heart
Tool Name RhythmAnalytics Ligence Heart
Company Biofourmis Singapore Pte. Ligence
Primary Data Input Single-lead ECG data 2D transthoracic echocardiography
Core AI Purpose Automated interpretation of cardiac arrhythmias for clinical decision support Automated analysis and reporting of echocardiography
Target Medical Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology
Specific Analytical Capability Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) Automated recognition of echocardiography imaging data; Automated calculation of measurements and report generation

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Ligence Heart.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics by Biofourmis is designed for automated interpretation of cardiac arrhythmias from single-lead ECG data. Ligence Heart, on the other hand, automates the analysis and reporting of 2D transthoracic echocardiography imaging data.
RhythmAnalytics detects over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. Ligence Heart provides automated measurements and disease recognition for conditions such as heart failure, cardiomyopathy, pulmonary hypertension, and valvular heart diseases from echocardiograms.
RhythmAnalytics is a cloud-based API that can be integrated into existing cardiac monitoring solutions or directly into medical devices and wearable sensors. Ligence Heart offers integration with existing systems like PACS, EHR, and RIS for transferring echocardiography images and generating reports.
Ligence Heart explicitly features automated calculation of measurements and report generation for echocardiography, which clinicians can then edit and approve. RhythmAnalytics focuses on AI-powered automated interpretation of cardiac arrhythmias, providing clinical decision support for healthcare professionals.
RhythmAnalytics is applicable to Cardiology, Emergency Medicine, and Internal Medicine. Ligence Heart is specifically designed for Cardiology.
AI Tool Finder
AI-powered search. Results may not be comprehensive.